M1 Kliniken AG
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MKLNF research report →
Companywww.m1-kliniken.de
M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty and Trade. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine and cosmetic dermatology, as well as trades in pharmaceutical, biosimilars, and other medical products and devices in the areas of oncology, HIV, rheumatism, neurology, cardiovascular diseases, and narcotics.
- CEO
- Kilian Brenske
- IPO
- 2021
- Employees
- 366
- HQ
- Berlin, DE
Price Chart
Valuation
- Market Cap
- $214.81M
- P/E
- 19.83
- P/S
- 1.00
- P/B
- 2.98
- EV/EBITDA
- 9.79
- Div Yield
- 2.64%
Profitability
- Gross Margin
- 12.01%
- Op Margin
- 8.52%
- Net Margin
- 5.00%
- ROE
- 15.83%
- ROIC
- 12.37%
Growth & Income
- Revenue
- $339.18M · 7.23%
- Net Income
- $16.02M · 55.91%
- EPS
- $0.86 · 59.26%
- Op Income
- $26.75M
- FCF YoY
- 334.57%
Performance & Tape
- 52W High
- $11.73
- 52W Low
- $11.73
- 50D MA
- $11.73
- 200D MA
- $11.73
- Beta
- 1.14
- Avg Volume
- 437
Get TickerSpark's AI analysis on MKLNF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MKLNF Coverage
We haven't published any research on MKLNF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MKLNF Report →